Roche Holding AG

RHHBF

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    103,605

Roche Holding AG News & Analysis

markets

Morningstar runs the numbers

We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended 10 January.
stocks

7 defensive stocks on sale

Equities have been in rally mode for most of the past decade and it's not unreasonable to suggest that playing a little defence right now might be a good idea.
video

Finding recession-proof companies

Morningstar's Peter Bull likes companies with pricing power and niche products, and names that catch his eye include Microsoft, Colgate and luxury retailers like Louis Vuitton and Christian Dior.  

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,484.1033.200.39%
CAC 407,216.8310.15-0.14%
DAX 4019,003.1130.53-0.16%
Dow JONES (US)43,958.1947.210.11%
FTSE 1008,030.334.560.06%
HKSE19,823.4523.43-0.12%
NASDAQ19,230.7250.68-0.26%
Nikkei 22538,883.71162.050.42%
NZX 50 Index12,651.8722.62-0.18%
S&P 5005,985.381.390.02%
S&P/ASX 2008,230.8037.400.46%
SSE Composite Index3,439.2817.310.51%

Market Movers